Imunon, Inc. (IMNN)
1.28
-0.04
(-3.03%)
USD |
NASDAQ |
Oct 02, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
Imunon Market Cap : 5.972M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.972M |
| October 01, 2026 | 6.159M |
| September 30, 2026 | 6.019M |
| September 29, 2026 | 6.229M |
| September 28, 2026 | 6.439M |
| September 25, 2026 | 6.579M |
| September 24, 2026 | 6.299M |
| September 23, 2026 | 6.859M |
| September 22, 2026 | 7.045M |
| September 21, 2026 | 6.672M |
| September 18, 2026 | 6.345M |
| September 17, 2026 | 6.439M |
| September 16, 2026 | 6.579M |
| September 15, 2026 | 6.532M |
| September 14, 2026 | 6.835M |
| September 11, 2026 | 6.859M |
| September 10, 2026 | 6.765M |
| September 09, 2026 | 7.045M |
| September 08, 2026 | 7.185M |
| September 04, 2026 | 7.372M |
| September 03, 2026 | 7.278M |
| September 02, 2026 | 7.278M |
| September 01, 2026 | 7.465M |
| August 31, 2026 | 7.605M |
| August 28, 2026 | 7.465M |
| Date | Value |
|---|---|
| August 27, 2026 | 7.465M |
| August 26, 2026 | 7.605M |
| August 25, 2026 | 7.745M |
| August 24, 2026 | 7.418M |
| August 21, 2026 | 7.652M |
| August 20, 2026 | 7.372M |
| August 19, 2026 | 7.372M |
| August 18, 2026 | 7.372M |
| August 17, 2026 | 7.465M |
| August 14, 2026 | 7.698M |
| August 13, 2026 | 7.372M |
| August 12, 2026 | 7.512M |
| August 11, 2026 | 7.512M |
| August 10, 2026 | 7.605M |
| August 07, 2026 | 7.512M |
| August 06, 2026 | 7.372M |
| August 05, 2026 | 6.237M |
| August 04, 2026 | 6.551M |
| August 03, 2026 | 6.198M |
| July 31, 2026 | 6.237M |
| July 30, 2026 | 6.276M |
| July 29, 2026 | 6.041M |
| July 28, 2026 | 6.002M |
| July 27, 2026 | 6.002M |
| July 24, 2026 | 5.923M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 356.27M |
| Amgen, Inc. | 217.88B |
| BioCryst Pharmaceuticals, Inc. | 2.086B |
| Curis, Inc. | 1.566M |
| CEL-SCI Corp. | 40.63M |
Market Cap Related Metrics
| Price to Book Value | 1.426 |
| Price | 1.28 |
| Earnings Yield | -300.2% |